Everlife-Research Instruments MY

24/05/2023

Thank you to Molecular Medicine University Malaya for hosting us in our talk "Enzymatic DNA Synthesis: Print your sequences in less than one day."

by

28/04/2023

Researchers can see the epigenetic landscape of their sequencing samples because of the special chemistry of HiFi sequencing.

In this recent publication, the scientists use simultaneous genome sequencing and epigenetic analysis to find a new bacterial defence system, showcasing the power of our approach.

Click here to read more: bit.ly/3MKVxAe

28/04/2023

Since acquiring the first in Australia, congrats to the Australian Genome Research Facility! We both concur that it will have significant effects in various areas, ranging from protecting endangered species to improving human health.

The Brisbane lab's will give researchers a more in-depth look at the genome at scale, enabling them to make the next significant advancement in biology.

https://www.agrf.org.au/news-and-media-releases/2023/4/19/agrf-continues-to-raise-the-bar-for-genomic-sequencing-in-australia

Media Release The latest in highly accurate long-read sequencing technology has arrived at AGRF. First in Australia and the region, the PacBio Revio offers dramatic improvements in the production of high precision HiFi reads at lower sequencing costs and symbolises an important shift in the accel

27/04/2023

Wonderful news! By purchasing numerous devices, DNA Link has just upped their genomics game, enabling them to offer their clients even higher quality data and services.

~ PacBio

“Exciting news! DNA Link just stepped up their genomics game by purchasing multiple units, allowing them to deliver even higher quality data and services to their customers. 👏”

27/04/2023

Learn from John Cumbers, founder of SynBioBeta, how a benchtop machine will transform the 40-year old synthesis industry by providing any easy to use system in every lab. John recently spoke with our CEO and Co-founder Thomas Ybert to understand why there is a shift towards enzymatic DNA synthesis by for and research.

Read the Forbes article to learn more

If you've worked as a researcher at any synbio company, you know the frustration of having to wait for DNA to be shipped to you. Thomas Ybert, co-founder and CEO of DNA Script, knows this feeling all too well - and this is why he decided to revolutionize the way scientists get their DNA.

26/04/2023

We are thrilled to announce that we are collaborating with Astellas Pharma who will license a suite of Twist’s VHH antibody libraries to be used for drug discovery and development.

“We are pleased to extend our collaboration with Astellas to three agreements across two groups within the company, showcasing our ability to meet the varying needs of our customers and support their success,” said Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “This latest collaboration with Astellas Pharma demonstrates how Twist can enable our customers to grow their pipelines both externally with our antibody discovery services and by supporting their internal discovery with our highly specific and potent antibody libraries.”

Read more here 👉 https://bit.ly/3mSPUWk

26/04/2023

Our latest blog post explores how the Revio system offers faster and more cost-effective long-read sequencing for metagenomics researchers, allowing for more high-quality and complete microbial datasets and access to new frontiers of discovery.

Learn more here: https://lnkd.in/eBd48VMK

Long-read metagenomcis on the Revio system enables researchers to access to more high-quality and complete microbial data than ever before.

26/04/2023

Congratulations MBRU!
As one of the first institutions to acquire this advanced sequencing technology, the PacBio Revio sequencer!

https://www.linkedin.com/feed/update/urn:li:activity:7052531728984281088?utm_source=share&utm_medium=member_desktop

26/04/2023

Another Revio milestone to celebrate! We are thrilled that Macrogen installed the first Revio system in Asia. We can't wait to see what game-changing discoveries they will uncover! 🎉 🌏

Another Revio milestone to celebrate! We are thrilled that Macrogen installed the first Revio system in Asia. We can't wait to see what game-changing…

20/04/2023

Selamat hari Raya Aidilfitri from all of us at Everlife Research Instruments Malaysia!
As we celebrate this festive occasion, let us embrace the spirit of forgiveness, unity, and generousity towards our fellow Malaysians. May this Hari Raya bring peace, love and joy to your hearts and homes.
Wishing you a blessed and meaningful celebration with your loved ones.

31/03/2023

Exciting news! We are thrilled to announce that Cell Signaling Technology has won "Antibody Supplier of the Year" award! We are proud to be at the forefront of this transformative technology and grateful for the hard work and dedication of the talented team. Kudos to the team on this achivements!🥳🥳

The 2023 CiteAb Awards results are in! We are honored to be recognized for our anti-CAR linker antibodies with the Innovation Award, and to be named Post Translational Modification (PTM) Antibody Supplier of the Year with the highest number of PTM antibody citations in 2022.

These two accolades, along with being Highly Commended for Antibody Supplier of the Year, are testaments to our ever-expanding portfolio of proven products and expert services.

Congratulations to all the nominees and winners, and many thanks to the team at CiteAb for their dedication to helping scientists find the right tools to advance their research. https://hubs.ly/Q01JcYy10

16/03/2023

⚡Limited Time Offer : Get 20% Off Conjugated Antibodies!⚡

Looking for high-quality antibodies for your research or diagnostics?
Take advantage of our limited time offer and get 20% off for conjugated antibodies!

Our antibodies are known for their high specificity, sensitivity, and reliability, and are used in a variety of applications, including cancer research, immunology, and drug discovery.

Don't miss out on this amazing deal. Shop now and use the code 23SBAF when placing your order!

Contact us if you would like to find out more.
☎️ 03-7859 1188
📧 [email protected]